Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

News Room

News Room Search
News Room List
NO Title Date Viewers
54 HanAll's Partner HBM Announces IND Approval for Phase 2 of Batoclimab in CIDP in China 2021-09-02 1901
53 HanAll Biopharma and Daewoong Pharmaceutical Invest $1M USD in Alloplex Biotherapeutics 2021-08-20 1931
52 HanAll Biopharma Reports Second Quarter 2021 Results 2021-07-28 2442
51 HanAll Biopharma Submits IND for Second Phase 3 (VELOS-3) of HL036 in Dry Eye Disease 2021-07-22 2229
50 HanAll's Partner HBM Announces Last Patient Dosing of Phase 1b/2a of Batoclimab in NMOSD 2021-07-19 1605
49 HanAll's Partner HBM Announces Positive Topline Results from Phase 2 of Batoclimab in MG 2021-07-07 1580
48 HanAll Biopharma Reports First Quarter 2021 Financial Results 2021-05-06 1906
47 HanAll Biopharma Appoints David Hernandez as Vice President of Clinical Development Operations 2021-04-13 1921
46 HanAll Biopharma, Restructured to Seung-kook Park and Seung-won Jeong Joint Representative System, Accelerating Advancement as a Global Biopharmaceutical Company 2021-03-29 1448
45 HanAll Biopharma’s Chinese Partner HBM Initiates the First Dosing of Phase 3 in Dry Eye Disease 2021-03-12 1247
1 2 현재 페이지3 4 5 6 7 8